Market Overview:
The global gonorrhea diagnostic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of gonorrhea, rising awareness about sexually transmitted diseases (STDs), and technological advancements in the field of diagnostics. The global gonorrhea diagnostic market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into flow cytometry, diagnostic imaging, gel micro-droplets, artificial intelligence, differential light scattering (DLS), liposomes monoclonal antibodies molecular diagnostics tests). On the basis of application,the market is segmented into hospital personal use research).
Product Definition:
A gonorrhea diagnostic is a test used to determine if someone has gonorrhea, a sexually transmitted infection (STI). Gonorrhea is caused by the bacteria Neisseria gonorrhoeae and can cause symptoms such as burning when urinating, discharge from the penis or vagina, and pain in the pelvic area. Left untreated, gonorrhea can lead to serious health problems. A gonorrhea diagnostic can help determine if someone has been infected with the bacteria and needs treatment.
Flow cytometry:
Flow cytometry is a technique that measures cell concentration and their characteristics. It is used for the identification of different types of cells in biological fluids such as blood, urine, serum or plasma. The main factors driving the growth factor in gonorrhea diagnostic market are increasing prevalence rate of gonorrhea and growing R&D activities to develop advanced techniques for early diagnosis.
Diagnostic imaging:
Diagnostic imaging is the branch of medical science that helps in obtaining information about a disease by using various devices. In present time, diagnostic imaging has evolved to be one of the most important tools for doctors while treating patients due to its ability to provide accurate and effective results. It provides information regarding location, nature and extent of damage in living tissues with high accuracy and precision.
Application Insights:
The research application segment held the largest share of over 70.0% in 2017. The growth is attributed to the rising number of R&D activities being undertaken by various organizations and institutions for developing a vaccine against GGC. The personal use segment is expected to exhibit the fastest CAGR during the forecast period owing to increasing awareness about gonorrhea among individuals, resulting in increased demand for diagnosis kits among them.
Hospital-based infections are highly costly and difficult to treat as they often require hospitalization and multiple courses of antibiotics, which can be expensive due these factors; hence, there has been an increase in demand for self-diagnosis using online resources or through word-of-mouth communication at a local level resulting in an upsurge in demand for point-of view tests such as guaiacolorphene test or urease test strips that help detect recent infections caused by GC bacteria (Gonorrhea Test).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, high adoption rate for advanced diagnostic technologies, and increasing healthcare expenditure in this region. The U.S., which accounted for the largest revenue share in North America, is also one of the most affected countries globally with around 1 million infections reported annually.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to improving healthcare infrastructure and rising awareness about early diagnosis among individuals infected with Gonorrhea bacteria.
Growth Factors:
- Increasing incidence of gonorrhea
- Rising demand for early diagnosis and treatment of gonorrhea
- Growing awareness about the benefits of early diagnosis and treatment of gonorrhea
- Technological advancements in diagnostic methods for gonorrhea
- Availability of affordable and accurate diagnostic tests for gonorrhea
Scope Of The Report
Report Attributes
Report Details
Report Title
Gonorrhea Diagnostic Market Research Report
By Type
Flow cytometry, Diagnostic imaging, Gel micro-droplets, Artificial intelligence, Differential light scattering (DLS), Liposomes, Monoclonal antibodies, Molecular diagnostics tests
By Application
Hospital, Personal use, Research
By Companies
Abott, Roche, Tosoh, Siemens, bioMerieux, PerkinElmer, Ortho Clinical Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Gonorrhea Diagnostic Market Report Segments:
The global Gonorrhea Diagnostic market is segmented on the basis of:
Types
Flow cytometry, Diagnostic imaging, Gel micro-droplets, Artificial intelligence, Differential light scattering (DLS), Liposomes, Monoclonal antibodies, Molecular diagnostics tests
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Personal use, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abott
- Roche
- Tosoh
- Siemens
- bioMerieux
- PerkinElmer
- Ortho Clinical Diagnostics
Highlights of The Gonorrhea Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Flow cytometry
- Diagnostic imaging
- Gel micro-droplets
- Artificial intelligence
- Differential light scattering (DLS)
- Liposomes
- Monoclonal antibodies
- Molecular diagnostics tests
- By Application:
- Hospital
- Personal use
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gonorrhea Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gonorrhea is a sexually transmitted infection that can cause problems with your reproductive system. Your doctor will ask about your sexual history and symptoms to determine if you have gonorrhea. A test called a urine test may be used to confirm the diagnosis.
Some of the major companies in the gonorrhea diagnostic market are Abott, Roche, Tosoh, Siemens, bioMerieux, PerkinElmer, Ortho Clinical Diagnostics.
The gonorrhea diagnostic market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gonorrhea Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gonorrhea Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gonorrhea Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gonorrhea Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gonorrhea Diagnostic Market Size & Forecast, 2020-2028
4.5.1 Gonorrhea Diagnostic Market Size and Y-o-Y Growth
4.5.2 Gonorrhea Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Flow cytometry
5.2.2 Diagnostic imaging
5.2.3 Gel micro-droplets
5.2.4 Artificial intelligence
5.2.5 Differential light scattering (DLS)
5.2.6 Liposomes
5.2.7 Monoclonal antibodies
5.2.8 Molecular diagnostics tests
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Personal use
6.2.3 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gonorrhea Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gonorrhea Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Flow cytometry
9.6.2 Diagnostic imaging
9.6.3 Gel micro-droplets
9.6.4 Artificial intelligence
9.6.5 Differential light scattering (DLS)
9.6.6 Liposomes
9.6.7 Monoclonal antibodies
9.6.8 Molecular diagnostics tests
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Personal use
9.10.3 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Flow cytometry
10.6.2 Diagnostic imaging
10.6.3 Gel micro-droplets
10.6.4 Artificial intelligence
10.6.5 Differential light scattering (DLS)
10.6.6 Liposomes
10.6.7 Monoclonal antibodies
10.6.8 Molecular diagnostics tests
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Personal use
10.10.3 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Flow cytometry
11.6.2 Diagnostic imaging
11.6.3 Gel micro-droplets
11.6.4 Artificial intelligence
11.6.5 Differential light scattering (DLS)
11.6.6 Liposomes
11.6.7 Monoclonal antibodies
11.6.8 Molecular diagnostics tests
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Personal use
11.10.3 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Flow cytometry
12.6.2 Diagnostic imaging
12.6.3 Gel micro-droplets
12.6.4 Artificial intelligence
12.6.5 Differential light scattering (DLS)
12.6.6 Liposomes
12.6.7 Monoclonal antibodies
12.6.8 Molecular diagnostics tests
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Personal use
12.10.3 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Flow cytometry
13.6.2 Diagnostic imaging
13.6.3 Gel micro-droplets
13.6.4 Artificial intelligence
13.6.5 Differential light scattering (DLS)
13.6.6 Liposomes
13.6.7 Monoclonal antibodies
13.6.8 Molecular diagnostics tests
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Personal use
13.10.3 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gonorrhea Diagnostic Market: Competitive Dashboard
14.2 Global Gonorrhea Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abott
14.3.2 Roche
14.3.3 Tosoh
14.3.4 Siemens
14.3.5 bioMerieux
14.3.6 PerkinElmer
14.3.7 Ortho Clinical Diagnostics
